Comparison of Repaglinide and Metformin Administered Alone or in Combination in Type 2 Diabetes
Status:
Completed
Trial end date:
2003-02-25
Target enrollment:
Participant gender:
Summary
This trial is conducted in Asia. The aim of this trial is to compare repaglinide and
metformin administered alone or in combination in subjects with type 2 diabetes.